Printer Friendly
The Free Library
14,588,739 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

E Med Future and AHSP Secure Agreement with Sullivan-Schein Dental to Distribute NeedleZap Dental.


Business Editors/Health/Medical Writers

COLUMBUS, Ohio--(BUSINESS WIRE)--May 11, 2004

E Med Future, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:EMDF), manufacturer of NeedleZap(R), announced that their exclusive sales and marketing partner, American Health American Health Inc. is a company that manufactures health supplements. It is located in Holbrook, New York. One of its products is labeled the "Chewable Original Papaya Enzyme" with the attached registered trademark, "The 'After Meal Supplement'".  & Safety Products, Inc. (AHSP AHSP Alpha-Hemoglobin Stabilizing Protein
AHSP Authority for Holding Sealed Particulars (India)
AHSP Academy of Health-Systems Pharmacists
), has secured an agreement with Sullivan-Schein Dental(R) to distribute NeedleZap(R) Dental to dental practitioners throughout the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. .

"NeedleZap(R) Dental was designed to fill a critical safety need in the dental market and Sullivan-Schein can help us increase product awareness and sales," said George Bregar, president, AHSP. "What's exciting is that we've already begun receiving excellent feedback from the dental community."

Sullivan-Schein Dental, a Henry Schein Henry Schein Inc. is a Fortune 500 company based in Melville, New York. It is a distributor of healthcare products and services primarily to office-based healthcare practitioners in the North American and European markets. The Company operates in two business segments.  Company, offers a broad array of products and services to dental customers. The company currently serves more than 75 percent of the dental practices in the United States.

NeedleZap(R) Dental is a small, portable device that disintegrates the needles used with dental aspirating syringes, reducing the risk and liability of accidental needlesticks, and assisting practices in complying with the OSHA OSHA
n.
Occupational Safety and Health Administration, a branch of the US Department of Labor responsible for establishing and enforcing safety and health standards in the workplace.
 Bloodborne Pathogen Pathogen

Any agent capable of causing disease. The term pathogen is usually restricted to living agents, which include viruses, rickettsia, bacteria, fungi, yeasts, protozoa, helminths, and certain insect larval stages.
 standards. When a used hypodermic needle hypodermic needle
n.
1. A hollow needle used with a hypodermic syringe.

2. A hypodermic syringe including the needle.
 is inserted into the unit, the patented electrode system disintegrates the needle in approximately two seconds at 2200 degrees F.

"With nearly 170,000 professionally active dentists in the United States alone, we anticipate the dental market to be an important audience for our sales success," said E Med Future President Robert J. Ochsendorf.

For more information about NeedleZap(R) Dental, contact AHSP at 866-862-7808 or visit www.ahsp.net. More information about E Med Future is available at www.needlezap.com.

Statements that describe E Med's future plans, objectives or goals are forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as E Med "expects," "anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of E Med, as appropriate, and market valuations of their stock, which could cause actual results to differ materially from those currently anticipated. Please refer to E Med's 10-K, 10-Qs and other filings with the SEC for a description of other factors that could cause actual results to differ from those anticipated.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 11, 2004
Words:364
Previous Article:Canadian Superior Awarded Major Gas Block in Historic Trinidad and Tobago Ministry of Energy and Energy Industries' 2003/2004 Competitive Bid Round.
Next Article:Empirix to Highlight Quality Assurance Solutions for Speech-Enabled Applications at Nuance V-World, May 17-20.
Topics:



Related Articles
Henry Schein Signs New Agreement to Exclusively Represent, Distribute ORALCDx, A Breakthrough Product in Oral Cancer Detection.
Aloha and congratulations! (Association Bulletin).
E Med Future, Inc. and UTEK Corporation Announce Strategic Alliance Agreement for Technology Transfer.
Mercury Medical to Distribute NeedleZap to Medical Markets.
E Med Future And AHSP Secure Agreement with NDC to Distribute NeedleZap to Medical and Dental Markets.
E Med Future and Ahsp Secure Agreement with Patterson Dental Supply.
E Med Future Establishes First of Six Distribution Centers in the United States.
Henry Schein and Sirona Dental Systems Expand Strategic Distribution Relationship into the United States.
ADAA annual awards for members.(American Dental Assistants Association)
Roll out the recognition.(ANNUAL CONFERENCE 2006)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles